9-ME-BC: what does this study show?
Cell-culture and enzyme experiments. Half-maximal enzyme inhibition occurred at 1 µM for MAO-A and 15.5 µM for MAO-B; these are assay concentrations, not human doses.
Neurotrophic-factor gene expression increased in astrocytes, with evidence implicating PI3K signaling. The compound also inhibited monoamine oxidase activity.
Cell findings cannot establish human recovery, cognition or safety. The abstract does not supply a clinical regimen or participant sample.
These findings apply to the population and methods described above.
What might this mean, and what would change the interpretation?
Cell findings cannot establish human recovery, cognition or safety. The abstract does not supply a clinical regimen or participant sample.
What would clarify this: Controlled human safety and efficacy research would be needed before clinical conclusions.
Findings reviewed · abstract
Checked Sep 23, 2026 against the linked abstract. This reading note is not a formal risk-of-bias appraisal.